期刊文献+

Visfatin mRNA在PCOS患者网膜脂肪组织中的表达 被引量:1

mRNA Expression of Visfatin in OmentalAdipose Tissue in Polycystic Ovary Syndrome
原文传递
导出
摘要 目的:探讨visfatin基因在多囊卵巢综合征(PCOS)网膜脂肪组织中的表达及相关影响因素。方法:采用半定量RT-PCR方法检测PCOS组(30例)和对照组(25例)网膜脂肪组织visfatin mRNA表达,并测量体重指数、腰臀比、空腹血糖、空腹胰岛素、胰岛素抵抗指数和血清性激素水平。结果:①PCOS组网膜脂肪组织visfatin mRNA表达量高于对照组(P=0.000)。②网膜脂肪组织visfatin mRNA的表达量与BMI、WHR、FINS、HOMA-IR呈正相关(P<0.05)。③多元逐步回归分析显示,HOMA-IR(P=0.000)和WHR(P=0.005)是影响网膜脂肪组织visfatin mRNA表达的相关因素。结论:网膜脂肪组织visfatin mRNA表达可能与PCOS胰岛素抵抗的发生和肥胖相关。 Objective: To investigate the mRNA expression of Visfatin in omental adipose tissue and its related factors in polyeystic ovary syndrome (PCOS). Methods: The mRNA expression ofvisfatin was measured using semiquantitative RT-PCR in omental adipose tissue in PCOS group (n=30) and control group (n=25) and body mass index (BMI), waist to hip ratio (WHR), fasting plasma glucose (FPG), fasting insulin (FINS), insulin resistance index and the levels of serum sexual hormones were measured. Results: ①The mRNA expression of visfatin in omental adipose tissue was significantly increased in PCOS group compared with control group (P=0.000). ② The mRNA expression ofvisfatin was positively correlated with BMI, WHR, FINS, HOMA-IR (P〈0.05). ③Multiple regression analysis demonstrated that HOMA-IR (P=0.000) and WHR (P=0.005) were related factors in influencing the mRNA expression ofvisfatin. Conelusions: The mRNA expression of visfatin in omental adipose tissue may be correlated with insulin resistance and obesity.
出处 《现代生物医学进展》 CAS 2009年第13期2514-2516,2537,共4页 Progress in Modern Biomedicine
关键词 VISFATIN 多囊卵巢综合征 胰岛素抵抗 Visfatin Polycystic ovary syndrome Insulin resistance
  • 相关文献

同被引文献29

  • 1Nestler JE,Jakubowicz DJ. Lean women with polycystic ovary syn- drome respond to insulin reduction with decreases in ovarian P450c17 alpha activity and serum androgens[ J]. J Clin Endocrinol Metab, 1997,82 ( 12 ) :4075 - 4079.
  • 2Thomann R, Rossinelli N, Keller U, et al. Differences in low-grade chronic inflammation and insulin resistance in women with previous gestational diabetes mellitus and women with polycystic ovary syn- drome [ J ]. Gynecol Endocrinol,2008,24 (4) : 199 - 206.
  • 3Hug C, Lodish HF. Medicine visfatin: a new adipokine [ J ]. Sci- ence,2005,307 (5708) :366 - 367.
  • 4Esteghamati A,Alamdari A,Zandieh A, et aL Serum visfatin is as- sociated with type 2 diabetes mellitus independent of insulin resist- ance and obesity [ J ]. Diabetes Res Pract,2011,91 ( 2 ) : 154 - 158.
  • 5Samal B, Sun Y, Stearns G, et al. Cloning and characterization of the cDNA encoding a novel human pre-B - cell colony-enhancing factor[J]. Mol Cell Biol,1994,14(2) :1431-1437.
  • 6Fukuhara A, Matsuda M,Nishizawa M, et al. Visfatin : a protein se- creted by visceral fat that mimics the effects of insulin[ J]. Science, 2005,207 (5708) :426 - 430.
  • 7Berndt J, Kloting N,Kralisch S,et al. Plasma visfatin concentrations and fat depot-specific mRNA expression in humans [ J ]. Diabetes, 2005,54(10) :2911 -2916.
  • 8Curat CA ,Wegner V ,Sengenes C ,et al. Macrophages in human vis- ceral adipose tissue:increased accumulation in obesity and a source of resistin and visfatin [ J ]. Diabetologia,2006,49 (4) :744 - 747.
  • 9Dahl TB, Yndestad A, Skjelland M, et al. Increased expression of visfatin in macrophages of human unstable carotid and coronary ath- erosclerosis:possible role in inflammation and plaque destabilization [ J]. Circulation ,2007,115 ( 8 ) :972 - 980.
  • 10Ognjanovic S, Bao S, Yamamoto SY, et al. Genomic organization of the gene coding for human pre - B - cell colony enhancing factor and expression in human fetal membranes[ J]. J Mol Endocrinol,2001, 26(2) :107 - 117.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部